<DOC>
	<DOCNO>NCT02928614</DOCNO>
	<brief_summary>This substudy randomize trial investigate effect liraglutide body weight pain overweight obese patient knee osteoarthritis ( NCT02905864 ) . In parent trial , patient subject 8-week diet intervention phase include low-calorie diet dietetic counseling , randomize receive either liraglutide 3 mg liraglutide 3 mg placebo add-on dietetic guidance re-introducing regular food focus continued motivation engage healthy lifestyle . This substudy aim investigate impact , subsequent change biomarkers obese patient knee osteoarthritis follow randomization Liraglutide 3 mg Liraglutide 3 mg placebo treatment week 0-52 .</brief_summary>
	<brief_title>Biomarkers Obese Patients With Knee Osteoarthritis ; Weight Maintenance</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Liraglutide</mesh_term>
	<criteria>Same parent trial ( NCT02905864 ) Same parent trial ( NCT02905864 )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Osteoarthritis</keyword>
	<keyword>Obesity</keyword>
	<keyword>Liraglutide 3 mg</keyword>
	<keyword>Liraglutide</keyword>
	<keyword>Biomarkers</keyword>
</DOC>